Eiger BioPharmaceuticals Garners $6,000,000 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b3fd3bfd-2aa2-438e-8ecc-4f54329c677f
Date
11/23/2015
Company Name
Eiger BioPharmaceuticals
Mailing Address
350 Cambridge Ave. Palo Alto, CA 94306 USA
Company Description
Eiger BioPharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis.
Website
http://www.eigerbio.com
Transaction Type
Debt
Transaction Amount
$6,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt.
M&A Terms
Venture Investor
Undisclosed